Maternal Alloimmunization Foundation

Nonprofit profile at a glance

EIN: 863579906
IRS 990-EZ coverage: 2022–2024
Forms available: Form 990-EZ 2024, Form 990-N 2021
Location: Batavia, IL, USA
Phone: 6306692292
Rating: 56
Verdict: MIXED
Rating confidence: Moderate
Sector: Alliance/Advocacy Organizations

Reported finances

Revenue: $105,277
Expenses: $43,577
Assets: $90,876

Source: IRS Form 990-EZ. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

6 people listed

Executive titles in this filing

JESSICA MOLITOR (President)

People named in this filing

JESSICA MOLITOR (President)
AMANDA LATERVEER (Treasurer)
STEPHANIE MCCARY (Director)

Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.

Source: IRS Form 990-EZ. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

Our mission is to provide advocacy and support to those affected by maternal alloimmunization and its comorbid condition, hemolytic disease of the fetus and newborn. Maternal Alloimmunization Foundation aims to prevent stillbirth and neonatal mortality and morbidity caused by HDFN. We intend to provide patient support through education and have the intent to aid in the improvement of health-care practices for the conditions.

Operating model

Revenue model: Cannot be determined from the filing. The filing does not provide enough consistent revenue detail to tell how this nonprofit funds its work.
Distribution model: Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

MIXED - The filed numbers largely add up and revenue comfortably covers expenses. A relatively small share of available resources goes toward mission work and a relatively small share of total spending goes to programs.

Rating breakdown

Financial Efficiency: 25
Transparency & Controls: 100
Sustainability: 76
Growth: 0

Detailed rating inputs

Financial Efficiency

Mission deployment rate: 16.4%; rating input score 16
Program expense ratio: 39.7%; rating input score 40

Transparency & Controls

Consistency checks: 100%; rating input score 100; 52nd percentile among comparable filings
Major donor itemization: Yes; rating input score 100

Sustainability

Operating margin: 58.6%; rating input score 95; 95th percentile among comparable filings
Total-asset coverage ratio: 2.09; rating input score 81; 81st percentile among comparable filings
Liabilities to assets ratio: Limited
Officer compensation ratio: 0%; rating input score 63; 63rd percentile among comparable filings

Growth

Program expense growth: -3.6% per year; rating input score 0; 21st percentile among comparable filings
Revenue growth: -29.6% per year; rating input score 0; 1st percentile among comparable filings
Asset growth: -29.1% per year; rating input score 0; 5th percentile among comparable filings

Details

Where the money goes: 16.4% of revenue deployed · 39.7% of spending went to programs
Governance: Filed governance answers
Accomplishments: 1 filed program accomplishment · $17K in reported program spending
Leadership: top reported pay $0 · 6 people listed
Consistency: 6 of 6 current checks pass
Schedules: 3 filed schedules
Filing history: 3 filing years from 2022 to 2024
Contacts: How to reach this organization
Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

High — Financial Efficiency: Mission deployment rate scored 16/100.
Moderate — Financial Efficiency: Program expense ratio scored 40/100.
High — Growth: Program expense growth scored 0/100.
High — Growth: Revenue growth scored 0/100.
High — Growth: Asset growth scored 0/100.